Position in EXEL
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$112,411
+$33,322 QoQ
Shares Held
2,066
+12.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#597
of 751 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WPG Advisers, LLC holds $865,405 across 47 Biotechnology names. EXEL ranks #3 (13.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
268 | $133,123 | |
| 2 | INCY |
Incyte Corp
|
994 | $112,679 | |
| 3 | EXEL |
Exelixis, Inc.
This page
|
2,066 | $112,411 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
384 | $92,532 | |
| 5 | ARGX |
Argenx SE
|
95 | $88,138 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
980 | $79,879 | |
| 7 | ABVX |
Abivax S.A.
|
432 | $57,568 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
251 | $24,467 |
All Filings in EXEL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $112,411 | 2,066 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $79,089 | 1,844 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $89,457 | 2,041 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $87,845 | 2,127 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $95,168 | 2,159 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $76,276 | 2,066 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $84,082 | 2,525 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||